stockrowSAB Biotherapeutics, Inc. (SABS) vs ARS Pharmaceuticals, Inc. (SPRY)
- SAB Biotherapeutics, Inc. SABS 3.00 +2.04%
- ARS Pharmaceuticals, Inc. SPRY 2.81 +6.04%
SAB Biotherapeutics, Inc. and ARS Pharmaceuticals, Inc. are both Biotechnology companies. SAB Biotherapeutics, Inc. and ARS Pharmaceuticals, Inc. are of similar size ($267.5M and $263.5M). ARS Pharmaceuticals, Inc. grew revenue faster over the last twelve months: −14.5% against −60.3%. Across the 16 metrics below, ARS Pharmaceuticals, Inc. leads on 9 and SAB Biotherapeutics, Inc. on 7.
Valuation
Profitability
| Metric | SABS | SPRY | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 0.00% | 68.51% |
| Operating margin | 0.00% | (161.50%) | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | (149.89%) | 0.00% |
| Return on equity | (34.27%) | 0.00% | (51.96%) |
| Return on assets | (28.97%) | 0.00% | (46.06%) |
| Return on invested capital | (38.97%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack